Unlocking the Power of
Natural Killer Cell Therapeutics

Precision Stem Cell Engineering to Unlock the Power of NK Cells

“We are excited to collaborate with Cellectis, a gene-editing pioneer and leader in the de

See All News & Events

The Power of Combining iPSC-Derived NK Cell Therapy & NK Cell Engager Antibodies
(Cell & Gene Therapy Insights)

August 1st, 2022

Cytovia Presents New Preclinical Data for Its GPC3 Flex-NK™ Cell Engager Antibody in Combination With NK Cells at ESMO 2022 in Paris

September 12th, 2022

Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Congress

June 10th, 2022

What's New at Cytovia